Security
Arcus Biosciences, Inc. · RCUS
RCUSNYSECommon stockCurrentCIK 1724521Updated Oct 26, 2026
RCUS price & chart
Loading TradingView…
NYSE:RCUS on TradingView ↗In the news
Recent filings
Other Events
Items 8.01, 9.01
424B5 filing
424B5 filing
Results of Operations and Financial Condition
Items 2.02
Other Events
Items 8.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 974,000,000Source | 1,252,000,000Source | 924,000,000Source | 1,075,000,000Source | 1,186,000,000Source | 997,000,000Source | 1,156,000,000Source | 1,293,000,000Source | 1,139,000,000Source | 1,150,000,000Source | 1,095,000,000Source | 1,345,000,000Source |
| Property, Plant and Equipment, NetUSD | 42,000,000Source | 48,000,000Source | 36,000,000Source | 44,000,000Source | 49,000,000Source | 38,000,000Source | 46,000,000Source | 51,000,000Source | 40,000,000Source | 47,000,000Source | 51,000,000Source | 35,000,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 238,000,000Source | 201,000,000Source | 150,000,000Source | 248,000,000Source | 156,000,000Source | 201,000,000Source | 192,000,000Source | 185,000,000Source | 222,000,000Source | 150,000,000Source | 127,000,000Source | 206,000,000Source |
| Assets, CurrentUSD | 857,000,000Source | 1,127,000,000Source | 756,000,000Source | 946,000,000Source | 1,022,000,000Source | 844,000,000Source | 1,031,000,000Source | 1,064,000,000Source | 1,007,000,000Source | 1,016,000,000Source | 831,000,000Source | 1,067,000,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 15,000,000Source | 22,000,000Source | 18,000,000Source | 20,000,000Source | 25,000,000Source | 19,000,000Source | 19,000,000Source | 34,000,000Source | 15,000,000Source | 18,000,000Source | 34,000,000Source | 19,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | — | — | — | — | — | — | 58,000,000Source | 65,000,000Source | 92,000,000Source | 100,000,000Source |
| Other Assets, NoncurrentUSD | 65,000,000Source | 75,000,000Source | 59,000,000Source | 69,000,000Source | 75,000,000Source | 61,000,000Source | 71,000,000Source | 78,000,000Source | 63,000,000Source | 73,000,000Source | 106,000,000Source | 114,000,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Common Stock, Value, IssuedUSD | 1,815,000,000Source | 1,602,000,000Source | 2,169,000,000Source | 1,793,000,000Source | 1,582,000,000Source | 2,138,000,000Source | 1,775,000,000Source | 1,561,000,000Source | 2,116,000,000Source | 1,617,000,000Source | 1,311,000,000Source | 1,206,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,379,000,000Source | -1,038,000,000Source | -1,704,000,000Source | -1,244,000,000Source | -946,000,000Source | -1,613,000,000Source | -1,244,000,000Source | -853,000,000Source | -1,485,000,000Source | -1,132,000,000Source | -849,000,000Source | -542,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | 1,000,000Source | -1,000,000Source | — | -1,000,000Source | -1,000,000Source | — | -1,000,000Source | — | — | 0Source | -7,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 436,000,000Source | 565,000,000Source | 464,000,000Source | 549,000,000Source | 635,000,000Source | 524,000,000Source | 531,000,000Source | 707,000,000Source | 631,000,000Source | 485,000,000Source | 462,000,000Source | 657,000,000Source |
| Liabilities and EquityUSD | 974,000,000Source | 1,252,000,000Source | 924,000,000Source | 1,075,000,000Source | 1,186,000,000Source | 997,000,000Source | 1,156,000,000Source | 1,293,000,000Source | 1,139,000,000Source | 1,150,000,000Source | 1,095,000,000Source | 1,345,000,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 235,000,000Source | 215,000,000Source | 198,000,000Source | 210,000,000Source | 199,000,000Source | 209,000,000Source | 192,000,000Source | 204,000,000Source | 231,000,000Source | 226,000,000Source | 184,000,000Source | 193,000,000Source |
| Operating Lease, Liability, CurrentUSD | 13,000,000Source | 11,000,000Source | 13,000,000Source | 12,000,000Source | 11,000,000Source | 13,000,000Source | 12,000,000Source | 11,000,000Source | 13,000,000Source | 12,000,000Source | 11,000,000Source | 3,000,000Source |
| Accounts Payable, CurrentUSD | 42,000,000Source | 13,000,000Source | 34,000,000Source | 29,000,000Source | 15,000,000Source | 39,000,000Source | 22,000,000Source | 16,000,000Source | 42,000,000Source | 18,000,000Source | 17,000,000Source | 20,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | — | — | — | — | — | — | 86,000,000Source | 99,000,000Source | 110,000,000Source | 117,000,000Source |
| Other Liabilities, NoncurrentUSD | 152,000,000Source | 136,000,000Source | 124,000,000Source | 159,000,000Source | 138,000,000Source | 119,000,000Source | 166,000,000Source | 140,000,000Source | 135,000,000Source | 157,000,000Source | 142,000,000Source | 140,000,000Source |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | — |
| Long-term DebtUSD | 98,000,000Source | 47,000,000Source | 101,000,000Source | 97,000,000Source | — | 100,000,000Source | 48,000,000Source | — | 99,000,000Source | 48,000,000Source | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -128,000,000Source | -112,000,000Source | -353,000,000Source | -283,000,000Source | -307,000,000Source | -267,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 19,000,000Source | 16,000,000Source | 60,000,000Source | 76,000,000Source | 73,000,000Source | 65,000,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -3,000,000Source | 3,000,000Source | 24,000,000Source | 3,000,000Source | -1,000,000Source | 8,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -138,000,000Source | -132,000,000Source | -482,000,000Source | -170,000,000Source | -306,000,000Source | 438,000,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 114,000,000Source | 32,000,000Source | 66,000,000Source | -84,000,000Source | 194,000,000Source | -413,000,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | 0Source | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 0Source | 1,000,000Source | 2,000,000Source | 6,000,000Source | 24,000,000Source | 6,000,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | — | — | 0Source | 7,000,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 3,000,000Source | 142,000,000Source | 488,000,000Source | 277,000,000Source | 33,000,000Source | 33,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -21,000,000Source | 42,000,000Source | 72,000,000Source | 23,000,000Source | -79,000,000Source | 58,000,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 7,000,000Source | 1,000,000Source | — | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 14,000,000Source | 19,000,000Source | 15,000,000Source | 15,000,000Source | 19,000,000Source | 16,000,000Source | 60,000,000Source | 76,000,000Source | 73,000,000Source | 65,000,000Source |
| General and Administrative ExpenseUSD | — | — | 27,000,000Source | 30,000,000Source | 24,000,000Source | 29,000,000Source | 29,000,000Source | 28,000,000Source | 110,000,000Source | 120,000,000Source | 117,000,000Source | 104,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 1,000,000Source | 6,000,000Source | 1,000,000Source |
| InterestExpenseNonoperatingUSD | — | — | 3,000,000Source | 1,000,000Source | 3,000,000Source | 2,000,000Source | 3,000,000Source | 1,000,000Source | 8,000,000Source | 4,000,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -135,000,000Source | -92,000,000Source | -91,000,000Source | 0Source | -128,000,000Source | -112,000,000Source | -353,000,000Source | -283,000,000Source | -307,000,000Source | -267,000,000Source |
| Nonoperating Income (Expense)USD | — | — | 7,000,000Source | 13,000,000Source | 5,000,000Source | 8,000,000Source | 6,000,000Source | 10,000,000Source | 33,000,000Source | 48,000,000Source | 39,000,000Source | 14,000,000Source |
| Operating ExpensesUSD | — | — | 168,000,000Source | 153,000,000Source | 137,000,000Source | 168,000,000Source | 151,000,000Source | 150,000,000Source | 633,000,000Source | 588,000,000Source | 457,000,000Source | 392,000,000Source |
| Operating Lease, Impairment LossUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | 20,000,000Source | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 142,000,000Source | 429,000,000Source | 228,000,000Source | 25,000,000Source | — |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 26,000,000Source | 48,000,000Source | 33,000,000Source | 160,000,000Source | 17,000,000Source | 28,000,000Source | 247,000,000Source | 258,000,000Source | 117,000,000Source | 112,000,000Source |
| Operating Income (Loss)USD | — | — | -142,000,000Source | -105,000,000Source | -96,000,000Source | -8,000,000Source | -134,000,000Source | -122,000,000Source | -386,000,000Source | -330,000,000Source | -340,000,000Source | -280,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -135,000,000Source | -92,000,000Source | -91,000,000Source | 0Source | -128,000,000Source | -112,000,000Source | -353,000,000Source | -282,000,000Source | -301,000,000Source | -266,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 1,000,000Source | 6,000,000Source | 1,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -135,000,000Source | -92,000,000Source | -91,000,000Source | 0Source | -128,000,000Source | -112,000,000Source | -353,000,000Source | -283,000,000Source | -307,000,000Source | -267,000,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -1.27Source | -1Source | -0.72Source | 0Source | -1.02Source | -1.14Source | -3.29Source | -3.14Source | -4.15Source | -3.71Source |
| Earnings Per Share, DilutedUSD per share | — | — | -1.27Source | -1Source | -0.72Source | 0Source | -1.02Source | -1.14Source | -3.29Source | -3.14Source | -4.15Source | -3.71Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 106,500,000Source | 91,400,000Source | 126,100,000Source | 106,100,000Source | 125,400,000Source | 98,400,000Source | 107,400,000Source | 90,100,000Source | 74,000,000Source | 72,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 106,500,000Source | 91,400,000Source | 126,100,000Source | 106,500,000Source | 125,400,000Source | 98,400,000Source | 107,400,000Source | 90,100,000Source | 74,000,000Source | 72,000,000Source |
| Interest Expense (non-operating)USD | — | — | 3,000,000Source | 1,000,000Source | 3,000,000Source | 2,000,000Source | 3,000,000Source | 1,000,000Source | 8,000,000Source | 4,000,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 2,000,000Source | 3,000,000Source | 10,000,000Source | 10,000,000Source | 8,000,000Source | 6,000,000Source |
| General and Administrative ExpenseUSD | — | — | 27,000,000Source | 30,000,000Source | 24,000,000Source | 29,000,000Source | 29,000,000Source | 28,000,000Source | 110,000,000Source | 120,000,000Source | 117,000,000Source | 104,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -353,000,000Source | -283,000,000Source | -301,000,000Source | -267,000,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | — | — | — | — | — | — | — | — | -4.15Source | -3.71Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | — | — | — | — | — | — | — | — | -4.15Source | -3.71Source |
| Interest Expense, DebtUSD | — | — | 4,000,000Source | 1,000,000Source | 3,000,000Source | 1,000,000Source | 3,000,000Source | 2,000,000Source | 9,000,000Source | 2,000,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 7,000,000Source | 13,000,000Source | 5,000,000Source | 8,000,000Source | 6,000,000Source | 10,000,000Source | 33,000,000Source | 48,000,000Source | 39,000,000Source | 14,000,000Source |
| Operating ExpensesUSD | — | — | 168,000,000Source | 153,000,000Source | 137,000,000Source | 168,000,000Source | 151,000,000Source | 150,000,000Source | 633,000,000Source | 588,000,000Source | 457,000,000Source | 392,000,000Source |
| Research and Development ExpenseUSD | — | — | 141,000,000Source | 123,000,000Source | 113,000,000Source | 139,000,000Source | 122,000,000Source | 122,000,000Source | 523,000,000Source | 448,000,000Source | 340,000,000Source | 288,000,000Source |
Offerings
Registration 333-293750
Filing attachments
d274489dex44.htm · S-3ASR · 2026-02-25
Exhibit 4.4 ARCUS BIOSCIENCES, INC. INDENTURE Dated as of ___________, 20___ [ ] Trustee TABLE OF CONTENTS Page ARTICLE I. DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1. Definitions 1 Section 1.2. …
Read attachment ↗